HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

O George Negrea Selected Research

Therapeutics

11/2016Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


O George Negrea Research Topics

Disease

1Hemorrhage
11/2016
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2016

Drug/Important Bio-Agent (IBA)

1veltuzumabIBA
11/2016

Therapy/Procedure

1Subcutaneous Injections
11/2016
1Therapeutics
11/2016